Department of Psychiatry, University of Oxford, Oxford, UK.
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, London, UK.
Mol Psychiatry. 2023 May;28(5):1902-1918. doi: 10.1038/s41380-023-01949-9. Epub 2023 Jan 23.
Cognitive deficits are a core feature of schizophrenia, account for much of the impaired functioning associated with the disorder and are not responsive to existing treatments. In this review, we first describe the clinical presentation and natural history of these deficits. We then consider aetiological factors, highlighting how a range of similar genetic and environmental factors are associated with both cognitive function and schizophrenia. We then review the pathophysiological mechanisms thought to underlie cognitive symptoms, including the role of dopamine, cholinergic signalling and the balance between GABAergic interneurons and glutamatergic pyramidal cells. Finally, we review the clinical management of cognitive impairments and candidate novel treatments.
认知缺陷是精神分裂症的核心特征,导致了与该疾病相关的大部分功能障碍,并且对现有治疗方法没有反应。在这篇综述中,我们首先描述了这些缺陷的临床表现和自然病史。然后,我们考虑了病因因素,强调了一系列类似的遗传和环境因素如何与认知功能和精神分裂症都有关联。接着,我们回顾了被认为是认知症状基础的病理生理机制,包括多巴胺、胆碱能信号传递以及 GABA 能中间神经元和谷氨酸能锥体神经元之间的平衡。最后,我们综述了认知障碍的临床管理和候选新型治疗方法。
Mol Psychiatry. 2023-5
Prog Neuropsychopharmacol Biol Psychiatry. 2005-2
Adv Neurobiol. 2017
Trends Neurosci. 2011-12-6
Acta Pharmacol Sin. 2018-3-22
Neurosci Biobehav Rev. 2023-5
World Psychiatry. 2020-2
Methods Mol Biol. 2023
Encephale. 2006
Eur Neuropsychopharmacol. 2013-12-14
Behav Genet. 2025-8-21
J Neural Transm (Vienna). 2025-8-8
Trends Pharmacol Sci. 2022-12
Br J Psychiatry. 2022-12
Schizophrenia (Heidelb). 2022-4-7
Biol Psychiatry. 2022-11-15